Interleukin-2 Administration Causes Reversible Hemodynamic Changes and Left Ventricular Dysfunction Similar to Those Seen in Septic Shock
- 1 October 1988
- journal article
- research article
- Published by Elsevier BV in Chest
- Vol. 94 (4), 750-754
- https://doi.org/10.1378/chest.94.4.750
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock.JCI Insight, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.JCI Insight, 1985
- Left ventricular performance in septic shock: Reversible segmental and global abnormalitiesAmerican Heart Journal, 1985
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- IN VIVO ADMINISTRATION OF INTERLEUKIN-2 ENHANCES SPECIFIC ALLOIMMUNE RESPONSESTransplantation, 1983
- Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: Validation of the technique and assessment of variabilityThe American Journal of Cardiology, 1979
- Hemodynamic Measurements in Bacteremia and Septic Shock in ManThe Journal of Infectious Diseases, 1973
- Hemodynamic studies and results of therapy in 50 patients with bacteremic shockAmerican Journal Of Medicine, 1973